Indaptus Therapeutics is trading at $2.24, up +5.66%, with no verified company-specific announcement explaining the October 2 move; broader market gains may be supporting shares, though a direct link is unconfirmed. - The S&P 500 is up 0.99%, the Nasdaq 1.56%, and the Dow 0.62%. - Shares closed at $2.12 on October 1, down 7.83%; recent coverage described earlier declines without an identified catalyst.